Credit Agricole’s Catalyst Pharmaceutical CPRX Stock Holding History

Credit Agricole’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,000	Closed	-$1.09M	–	1323
2026 Q1	$1.09M	Buy	+44,000	New	+$1.05M	﹤0.01%	1056
2025 Q1	$2.08M	Hold	85,761	–	–	0.01%	737
2024 Q4	$1.79M	Buy	85,761 +57,642	+205%	+$1.24M	0.01%	768
2024 Q3	$559K	Buy	+28,119	New	+$521K	﹤0.01%	924
2022 Q1	–	Sell	-10,000	Closed	-$68K	–	717
2021 Q4	$68K	Hold	10,000	–	–	﹤0.01%	501
2021 Q3	$53K	Hold	10,000	–	–	﹤0.01%	500
2021 Q2	$58K	Hold	10,000	–	–	﹤0.01%	479
2021 Q1	$46K	Hold	10,000	–	–	﹤0.01%	456
2020 Q4	$33K	Buy	+10,000	New	+$33.6K	﹤0.01%	424

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Agricole's CPRX Position: Q2 2026 in Review

Credit Agricole sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 44,000 shares — an estimated $1.09M sold.

Credit Agricole first reported a position in CPRX in Q4 2020 and held it in 9 quarters. The position peaked at $2.08M in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Credit Agricole reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Credit Agricole sold 44,000 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.09M.
Credit Agricole first reported a position in Catalyst Pharmaceutical in Q4 2020 and held it in 9 quarters.
Credit Agricole's Catalyst Pharmaceutical position peaked at $2.08M in Q1 2025.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.